OKYO Pharma Ltd ADR (OKYO) Stock Analysis

OKYO Pharma Ltd ADR (OKYO) is a publicly traded company in the HEALTHCARE sector. It trades at $1.70, carries a market capitalization of $89.22M. This page summarizes the public market data, fundamentals, and frequently asked questions for OKYO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

OKYO Pharma Ltd ADR currently has a Bullish sentiment score of 0.43.

About OKYO Pharma Ltd ADR

OKYO Pharma Ltd ADR is a preclinical biopharmaceutical company based in London, UK, specializing in the development of innovative therapies for inflammatory eye diseases and ocular pain. The company is leveraging advanced research to address significant unmet medical needs in the ophthalmology sector. With a focused pipeline and a commitment to innovation, OKYO is positioned to potentially transform the landscape of ocular therapeutics, offering promising solutions for patients suffering from...

GNG Research Analysis

GNG Research scores OKYO Pharma Ltd ADR (OKYO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OKYO.

Frequently Asked Questions

Does OKYO pay dividends?

OKYO Pharma Ltd ADR (OKYO) does not currently pay a regular dividend.

What is OKYO's market cap?

OKYO Pharma Ltd ADR (OKYO) has a market capitalization of $89.22M with a current stock price of $1.70.